Clinical Trials Logo

Filter by:
NCT ID: NCT04319562 Not yet recruiting - Clinical trials for Subthreshold Depression

Needle-embedding Therapy Alleviates Depressive Symptoms and Resets the Function of Executive Control System in Subthreshold Depression People

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The main objective of this trial is to evaluate the effectiveness of treating subthreshold depression by needle-embedding therapy. On this basis, the investigators will discuss the mechanism of needle-embedding therapy improving executive function control system.

NCT ID: NCT04321889 Not yet recruiting - Stroke Clinical Trials

Efficacy of Defurocumarinized Bergamot in the Treatment of Agitation in Severe Dementia Patients.

BEO
Start date: April 1, 2020
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of defurocumarinized bergamot in the treatment of agitation in severe dementia patients. Bergamot essential oil (BEO), able to modulate the endogenous, peripheral and central opioid system involved in painful states, has developed in models of inflammatory pain and neuropathic pain; it is also effective when administered by inhalation. Participants in the study will be divided into 2 parallel groups, one treatment group and one placebo, to evaluate the clinical efficacy of defurocumarinized bergamot loaded in a nanotechnological system of essential oil release in the pharmaceutical form of a cream in the treatment of agitation, in in Over-sixty-five-year-old patients of both sexes diagnosed with severe dementia.

NCT ID: NCT04324177 Not yet recruiting - Critical Illness Clinical Trials

Profile of Pediatric Patients Admitted to AU ICU

Start date: April 1, 2020
Phase:
Study type: Observational

This study aims to determine the profile and outcome of children admitted to ICU at Assiut University children hospital in order to detect association between risk factors and outcome, to asses the efficacy of treatment making it possible to take better decisions , to improve the quality of care.

NCT ID: NCT04324411 Not yet recruiting - Autoimmune Anemia Clinical Trials

Sirolimus Combined With ATRA for the Treatment of Auto-Immune Anemia

Start date: April 1, 2020
Phase: Phase 2/Phase 3
Study type: Interventional

Autoimmune anemia (AIA), including autoimmune hemolytic anemia (AIHA), EVENs' syndrome (ES), acquired pure red aplastic anemia (PRCA), is a kind of anemia disease mediated by autoimmunity, which can be primary or secondary to other diseases including autoimmune disease, malignant tumor, infection, etc. Glucocorticoid is the first-line treatment. However, the recurrence rate is very high and some patients may not response to steroids, the latter defined as refractory autoimmune anemia (RAIA). Second-line therapies include cyclosporine A (CSA), cyclophosphamide, 6-mercaptopurine, CD20 monoclonal antibody, anti human lymphocyte immunoglobulin (ATG), and even splenectomy. Cyclosporine A is easy to accept while some patients may have side effects such as renal function damage, gingival hyperplasia, hypertension and so on. Other second-line drugs also have many problems, such as low effective rate, slow onset, expensive price, and large side effects, and some patients do not response to these treatments. The refractory/relapsed AIA patients have increased cardiovascular events, increased opportunities for infections, decreased quality of life, and even death. At present, there is still no effective treatment for these patients. Our previous retrospective study showed that sirolimus was effective in cyclosporine refractory PRCA with an effective rate of 70% and slight side effects. In addition, we used sirolimus in refractory AIHA and ES, with an effective rate of 60-70%. However, there are still some non-responsive patients. Recently, it has been reported that all trans retinoic acid (ATRA) combined with danazol was effective in the treatment of refractory immune thrombocytopenic purpura (ITP). Therefore, we plans to combine sirolimus and ATRA in the treatment of refractory AIA to improve the efficacy. Since both sirolimus and ATRA are cheap and have slight side effects, this combination may reduce the economic burden of patients and reduce the side effects related to treatment.

NCT ID: NCT04324775 Not yet recruiting - Clinical trials for Manual Lymphatic Drainage

Comparison of Acute Effect of Different Manual Techniques on Muscle Fascia Stiffness

Start date: April 1, 2020
Phase:
Study type: Observational

There are studies investigating the effect of different massage methods on muscle fascia stiffness but the results do not support each other. In addition, there is no study to investigate the effect of MLD on muscle fascia stiffness. The aim of this study is to determine the acute effect of MLD and classical (Swedish) massage (KM) on muscle fascia stiffness after exercise.

NCT ID: NCT04324866 Not yet recruiting - Clinical trials for Coronavirus Infection

Prevalence and Incidence of COVID-19 Infection in Patients With Chronic Plaque Psoriasis on Immunosuppressant Therapy

Start date: April 1, 2020
Phase:
Study type: Observational

This study will assess the prevalence and incidence of COVID-19 infection in patients with chronic plaque psoriasis on immunosuppressant therapy.

NCT ID: NCT04325269 Not yet recruiting - Lung Cancer Clinical Trials

Continuous Ambulatory ECG Monitoring for Detection of Postoperative Atrial Fibrillation Following Thoracic Surgery

Start date: April 1, 2020
Phase:
Study type: Observational

Atrial fibrillation (AF) is a common and serious complication after lung resection. The incidence is likely underestimated, and risk may persist after leaving hospital. Recent development of simple wearable patch ECG devices may provide sensitive detection of AF in the extended postoperative period. Specific biomarkers may allow us to predict which patients are at risk of developing postoperative AF.

NCT ID: NCT04326582 Not yet recruiting - Arthritis Clinical Trials

Arthritis in Assiut University Children Hospital

Start date: April 1, 2020
Phase:
Study type: Observational

- To define prevalence of different types of arthritis in patients attending Assiut University Children Hospital (AUCH) - To define prognosis of these different types - To evaluate management of arthritis in Assiut University Children Hospital, in comparison to international guidelines

NCT ID: NCT04327492 Not yet recruiting - Carotid Stenosis Clinical Trials

Hemathologic and Imagiologic Predictors of Stroke During Carotid Endarterectomy With Regional Anesthesia

Start date: April 1, 2020
Phase:
Study type: Observational [Patient Registry]

Establish and validate biomarkers which improve the predictive value of current risk stratification models for patients benefiting from carotid revascularization, outperform existing biomarkers, and reach clinical application standards.

NCT ID: NCT04329078 Not yet recruiting - Allergy;Food Clinical Trials

Relevance of Sensitization to Legumes in Children Allergic to Peanut

Start date: April 1, 2020
Phase:
Study type: Observational

The objectives of this study are to determine in children allergic to peanut (i) the prevalence of sensitization to other legumes, (ii) the prevalence of allergy to each legume in patients who are sensitized to it (iii ) the severity of the allergy to legumes other than peanut